Research on genomic medicine is growing rapidly, which raises challenges concerning the design of clinical trials, regulatory channels, manufacturing processes, and price structures. Sandy Macrae, Chief Executive Officer of Sangamo Therapeutics, Inc., will explain the new wave of medicine and the hurdles that need to be overcome in order to revolutionize the treatment of genetic illnesses in this article.
Expansion Cohorts In Clinical Trials Of Oncology Drugs: FDA Issues Guidance
FDA released the final guideline paper in March for first-in-human trial models that include both dosage escalation and various expansion cohorts to assess safety, anti-tumor
May 16, 2022
